Targeting Inflammation with New NLRP3 Inhibitors | Discovering BAL-0028 and BAL-0598 in Disease Treatment

In this episode of SciBud, join host Rowan as we delve into an exciting breakthrough in bioimaging that could transform our understanding of inflammation and age-related diseases. We spotlight a fascinating study on NLRP3, a key protein in the inflammation pathway linked to conditions like Alzheimer’s and heart disease. Researchers have introduced two innovative small molecules, BAL-0028 and BAL-0598, which show promise as specific inhibitors of NLRP3, potentially overcoming limitations of the existing MCC950 treatment. With the study employing a cutting-edge DNA-encoded chemical library to sift through over 500 billion compounds, BAL-0028 is already demonstrating remarkable effectiveness in human cells. However, differences in its performance in mouse models raise important questions about the potential for human applications. As we explore these findings, we'll uncover the implications for patients battling inflammatory diseases and discuss how these developments might impact health outcomes in the real world. Tune in to discover how science is advancing our fight against inflammation and enhancing medical treatments! Link to episode page with article citation: www.scibud.media/podcast/season/2025/episode/153